Press Releases

4Moving Biotech announces successful results from its Lasare Phase I 4P004 Clinical Trial intraarticular Liraglutide for knee osteoarthritis patients Jun 10, 2024 01:30AM

• Lasare Phase I clinical trial demonstrated acceptable safety and tolerability profiles of 4P004 intra-articular liraglutide for treating knee osteoarthritis
• 4Moving Biotech received constructive pre-IND guidance from the US Food and Drug Administration (FDA) in advancing its clinical development strategy with the potential for accelerated approval

LILLE, France & PARIS--(BUSINESS WIRE)-- 4Moving Biotech, a spin-off of 4P-Pharma committed to developing... (continue reading...)

BGHL (GBP): NAV(s) Jun 10, 2024 01:30AM

                                      BOUSSARD & GAVAUDAN HOLDING LIMITED

Ordinary Shares

The Directors of Boussard & Gavaudan Holding Limited would like to announce the following information for the Company.

Close of business 07 Jun 2024.

Estimated NAV

  Euro Shares Sterling Shares Estimated NAV €    28.0982 £    25.1939 Estimated MTD return      0.34 %      0.36 % Estimated YTD return      2.00 %      2.54 % Estimated ITD return ... (continue reading...)

BGHL (EUR): NAV(s) Jun 10, 2024 01:30AM

                                      BOUSSARD & GAVAUDAN HOLDING LIMITED

Ordinary Shares

The Directors of Boussard & Gavaudan Holding Limited would like to announce the following information for the Company.

Close of business 07 Jun 2024.

Estimated NAV

  Euro Shares Sterling Shares Estimated NAV €    28.0982 £    25.1939 Estimated MTD return      0.34 %      0.36 % Estimated YTD return      2.00 %      2.54 % Estimated ITD return ... (continue reading...)

Viridien launches new brand to accelerate growth as an advanced technology company Jun 10, 2024 01:30AM

Paris, France – June 10, 2024

Viridien, formerly CGG, today launched its new brand at the 2024 EAGE Annual Conference in Oslo, marking the next stage in its strategic growth as an Advanced Technology, Digital and Earth Data company.

Since this strategy was announced in 2018, the company has divested its data acquisition activities and increased the differentiation in its core businesses of Geoscience, Earth Data and Sensing & Monitoring. New Businesses are... (continue reading...)

Andrew Wilkinson Announces Philanthropic and Personal Transfer of Up to 3,100,000 Shares Jun 9, 2024 10:20PM

Victoria, British Columbia--(Newsfile Corp. - June 9, 2024) - Andrew Wilkinson announces that he has filed a Form 45-102F1 - Notice of Intention to Distribute Securities under Section 2.8 of NI 45-102 Resale of Securities (the "Sales Notice") in connection with the proposed disposition of up to 3,100,000 Class A common shares ("Shares") in the capital of Tiny Ltd. ("Tiny").

The proposed disposition includes:

• A significant donation of Shares to Mr. Wilkinson's private... (continue reading...)